Belkyra Treatment

A treatment to improve the appearance of a double chin.

A stubborn double chin can make you look older and heavier than you actually are. Now we can safely and effectively reduce the appearance of double chins with the non-surgical Belkyra Treatment.

About Double Chin Treatment

Non-surgical Belkyra Treatment is used to treat extra fullness below the chin, resulting in a more contoured neck profile and jawline.

How Belkyra Works

Belkyra injections contain a naturally occurring substance in the body, deoxycholic acid, which helps the body absorb fat cells. When properly injected, this substance destroys fat cells, effectively disolving a double chin.

What to expect

We use topical & subcutaneous local anaesthetic prior to your treatment to maximize your comfort. The Belkyra Treatment is then injected at the treatment site. Patients require 2 treatments (occasionally more, rarely up tom6) to achieve results, with each treatment is usually spaced a minimum of 8 weeks apart. The results can last up to 4 years!

Belkyra Treatment Pricing

Costs for the first 2 treatments (8 weeks apart), are $2500. Depending on face shape, dosage and number of treatments required

Payment Methods: Our PartPay programme allows you to pay 25% on day of treatment & then 25% every fortnight for 6 weeks, interest free.We also offer Q Card over 12 months.

Bookings

We offer a range of appointment times to suit your needs, including evenings and weekends.
Use our booking system to check availability or contact us to request a specific appointment time. Our out of hours appointments are by appointment only.

Check Availability & Book Now
Belkyra Double Chin Treatment - Before and After

Product Information:

BELKYRA® injection is a prescription medicine containing 10 mg/mL deoxycholic acid. It is used for the improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. Do not use in people allergic to this medicine, with infection at site of injection, pregnancy and lactation. Possible side effects include headaches, difficulty swallowing, nausea, skin tightness, hypertension, injection site bruising/pain/swelling/numbness/redness/tingling/hardness/itching/discolouration/formation of small areas of hardness/warmth and injection site nerve injury. BELKYRA® treatment is not funded on the New Zealand Pharmaceutical Schedule. You will need to pay for this medicine. Normal Doctors visit fees apply. BELKYRA® treatment should be administered only by trained medical professionals. Speak to your specialist about your own situation and about the benefits/risks of this procedure in appearance medicine. For further information, the Data Sheet and Consumer Medicines Information can be accessed at www.medsafe.govt.nz or ask your doctor. If you have any side effects or concerns speak to your doctor. Note: Results from BELKYRA® treatment usually last up to four years.

BELKYRA® and its design are trademarks of Kythera Biopharmaceuticals, Inc., an Allergan affiliate. ™Trademark of Allergan, Inc. Allergan Australia Pty Ltd, 810 Pacific Highway, Gordon NSW 2072. ABN 85 000 612 831. Allergan New Zealand Limited, Auckland. © 2018 Allergan.